Your browser doesn't support javascript.
loading
Influence of Nasopharyngeal Viral Load on the Spread of the Omicron BA.2 Variant.
Migueres, Marion; Dimeglio, Chloé; Mansuy, Jean-Michel; Abravanel, Florence; Raymond, Stéphanie; Latour, Justine; Jeanne, Nicolas; Ranger, Noémie; Lhomme, Sébastien; Saune, Karine; Tremeaux, Pauline; Izopet, Jacques.
Afiliação
  • Migueres M; Laboratoire de virologie, Institut fédératif de Biologie, Hôpital Purpan, CHU Toulouse, 31300 Toulouse, France.
  • Dimeglio C; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291-CNRS UMR5051, 31300 Toulouse, France.
  • Mansuy JM; Université Toulouse III Paul-Sabatier, 31062 Toulouse, France.
  • Abravanel F; Laboratoire de virologie, Institut fédératif de Biologie, Hôpital Purpan, CHU Toulouse, 31300 Toulouse, France.
  • Raymond S; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291-CNRS UMR5051, 31300 Toulouse, France.
  • Latour J; Université Toulouse III Paul-Sabatier, 31062 Toulouse, France.
  • Jeanne N; Laboratoire de virologie, Institut fédératif de Biologie, Hôpital Purpan, CHU Toulouse, 31300 Toulouse, France.
  • Ranger N; Laboratoire de virologie, Institut fédératif de Biologie, Hôpital Purpan, CHU Toulouse, 31300 Toulouse, France.
  • Lhomme S; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291-CNRS UMR5051, 31300 Toulouse, France.
  • Saune K; Université Toulouse III Paul-Sabatier, 31062 Toulouse, France.
  • Tremeaux P; Laboratoire de virologie, Institut fédératif de Biologie, Hôpital Purpan, CHU Toulouse, 31300 Toulouse, France.
  • Izopet J; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291-CNRS UMR5051, 31300 Toulouse, France.
Clin Infect Dis ; 76(3): e514-e517, 2023 02 08.
Article em En | MEDLINE | ID: mdl-35796540
We used variant typing polymerase chain reaction to describe the evolution of severe acute respiratory syndrome coronavirus 2 Omicron sublineages between December 2021 and mid-March 2022. The selective advantage of the BA.2 variant over BA.1 is not due to greater nasopharyngeal viral loads.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article